JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity.

Arts J, King P, Mariën A, Floren W, Beliën A, Janssen L, Pilatte I, Roux B, Decrane L, Gilissen R, Hickson I, Vreys V, Cox E, Bol K, Talloen W, Goris I, Andries L, Du Jardin M, Janicot M, Page M, van Emelen K, Angibaud P.

Open source

DOI
10.1158/1078-0432.ccr-09-0547
Published
2009-10-27
Container
Clin Cancer Res
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-09-0547,
  title = {JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity.},
  author = {Arts J and  King P and  Mariën A and  Floren W and  Beliën A and  Janssen L and  Pilatte I and  Roux B and  Decrane L and  Gilissen R and  Hickson I and  Vreys V and  Cox E and  Bol K and  Talloen W and  Goris I and  Andries L and  Du Jardin M and  Janicot M and  Page M and  van Emelen K and  Angibaud P.},
  year = {2009},
  journal = {Clin Cancer Res},
  doi = {10.1158/1078-0432.ccr-09-0547},
  url = {https://doi.org/10.1158/1078-0432.ccr-09-0547}
}

RIS

TY  - JOUR
TI  - JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity.
AU  - Arts J
AU  -  King P
AU  -  Mariën A
AU  -  Floren W
AU  -  Beliën A
AU  -  Janssen L
AU  -  Pilatte I
AU  -  Roux B
AU  -  Decrane L
AU  -  Gilissen R
AU  -  Hickson I
AU  -  Vreys V
AU  -  Cox E
AU  -  Bol K
AU  -  Talloen W
AU  -  Goris I
AU  -  Andries L
AU  -  Du Jardin M
AU  -  Janicot M
AU  -  Page M
AU  -  van Emelen K
AU  -  Angibaud P.
PY  - 2009
JO  - Clin Cancer Res
DO  - 10.1158/1078-0432.ccr-09-0547
UR  - https://doi.org/10.1158/1078-0432.ccr-09-0547
ER  - 

APA

J, A., P, K., A, M., W, F., A, B., L, J., I, P., B, R., L, D., R, G., I, H., V, V., E, C., K, B., W, T., I, G., L, A., M, D. J., M, J., M, P., K, V. E., & P., A. (2009). JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity.. Clin Cancer Res. https://doi.org/10.1158/1078-0432.ccr-09-0547

Source records